Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Cancer Investigation
|
October 24, 2007
Tyrosine kinase inhibitors in pediatric malignancies
Jeffrey M Skolnik, Peter C Adamson
Molecular Aspects of Medicine
|
November 6, 2023
Vaccines for HPV-associated diseases
Jeffrey M Skolnik, Matthew P Morrow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Pediatric phase I trials in oncology: an analysis of study conduct efficiency
Debra P Lee, Jeffrey M Skolnik, Peter C Adamson
Computer Methods and Programs in Biomedicine
|
February 16, 2008
A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation
Jeffrey S Barrett, Bhuvana Jayaraman, Dimple Patel, et al.
Cancer Chemotherapy and Pharmacology
|
September 28, 2005
A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer
Jeffrey M Skolnik, Jeffrey S Barrett, Heng Shi, et al.
The AAPS Journal
|
April 19, 2013
Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients
Jeffrey S Barrett, Dimple Patel, Erin Dombrowsky, et al.
Therapeutic Drug Monitoring
|
October 22, 2010
Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer
Jeffrey M Skolnik, Alena Y Zhang, Jeffrey S Barrett, et al.
Journal of Mass Spectrometry : JMS
|
May 19, 2007
A sensitive and selective liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer
James I Lee, Jeffrey M Skolnik, Jeffrey S Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
Shortening the timeline of pediatric phase I trials: the rolling six design
Jeffrey M Skolnik, Jeffrey S Barrett, Bhuvana Jayaraman, et al.
Cancer Chemotherapy and Pharmacology
|
May 25, 2012
Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children's oncology group
Alena Y Z Edwards, Jeffrey M Skolnik, Erin Dombrowsky, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Cancer Investigation
|
October 24, 2007
Tyrosine kinase inhibitors in pediatric malignancies
Jeffrey M Skolnik, Peter C Adamson
Molecular Aspects of Medicine
|
November 6, 2023
Vaccines for HPV-associated diseases
Jeffrey M Skolnik, Matthew P Morrow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Pediatric phase I trials in oncology: an analysis of study conduct efficiency
Debra P Lee, Jeffrey M Skolnik, Peter C Adamson
Computer Methods and Programs in Biomedicine
|
February 16, 2008
A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation
Jeffrey S Barrett, Bhuvana Jayaraman, Dimple Patel, et al.
Cancer Chemotherapy and Pharmacology
|
September 28, 2005
A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer
Jeffrey M Skolnik, Jeffrey S Barrett, Heng Shi, et al.
The AAPS Journal
|
April 19, 2013
Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients
Jeffrey S Barrett, Dimple Patel, Erin Dombrowsky, et al.
Therapeutic Drug Monitoring
|
October 22, 2010
Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer
Jeffrey M Skolnik, Alena Y Zhang, Jeffrey S Barrett, et al.
Journal of Mass Spectrometry : JMS
|
May 19, 2007
A sensitive and selective liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer
James I Lee, Jeffrey M Skolnik, Jeffrey S Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2008
Shortening the timeline of pediatric phase I trials: the rolling six design
Jeffrey M Skolnik, Jeffrey S Barrett, Bhuvana Jayaraman, et al.
Cancer Chemotherapy and Pharmacology
|
May 25, 2012
Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children's oncology group
Alena Y Z Edwards, Jeffrey M Skolnik, Erin Dombrowsky, et al.
Page
of 3